James Lind

James Lind: Twelve Sailors, Six Cures, and the Birth of the Clinical Trial

On 20 May 1747, in the Bay of Biscay, a naval surgeon aboard HMS Salisbury picked twelve sailors already sick with scurvy, paired them off, and gave each pair a different remedy while holding everything else about their diet and quarters identical. It was, in effect, the first controlled clinical trial in the history of medicine, and the result — two of the twelve sailors, the ones eating oranges and lemons, back on their feet within days — should have ended scurvy's reign over the Royal Navy almost immediately. It took another forty-eight years before the Navy acted on it.

From Edinburgh to the Fleet

Lind was born in Edinburgh in 1716 and educated at the Royal High School there before apprenticing to a surgeon and, in 1739, joining the Royal Navy as a surgeon's mate at the outset of the War of the Austrian Succession. Over the following years he served across the English Channel, the Atlantic, the Mediterranean, West Africa, and the West Indies — a punishing tour that exposed him first-hand to the disease that killed more sailors on long voyages than combat did: scurvy, whose victims suffered bleeding gums, reopened old wounds, exhaustion, and eventually death, all from a cause nobody in naval medicine could reliably identify. By 1747 he had risen to ship's surgeon aboard HMS Salisbury.

Twelve Patients, Six Treatments

Lind's trial design, for its time, was unusually rigorous. He selected twelve sailors with comparable, active cases of scurvy, housed them together under the same conditions, and fed them the same basic shipboard diet — then added, in pairs, six different supplementary treatments then in circulation as supposed scurvy cures: a quart of cider daily; twenty-five drops of elixir of vitriol (dilute sulfuric acid); two spoonfuls of vinegar; half a pint of seawater; a spicy paste washed down with barley water; and, for the sixth pair, two oranges and one lemon a day, a treatment discontinued after only six days because the ship's supply ran out. Even that brief exposure was enough: one of the two citrus-fed sailors was fit for duty within six days, the other nearly recovered, while every other group showed at best a marginal improvement over no treatment at all. Lind had not set out with a theory to prove — he tested the era's competing folk and medical remedies side by side and let the outcome decide, an approach he later described as resting "upon attested facts and observations, without suffering the illusions of theory to influence and pervert the judgement."

The Treatise and the Silence That Followed

Lind left active naval service the following year, completed his MD at Edinburgh in 1748, and spent several years in private practice before publishing his findings at length in A Treatise of the Scurvy in 1753, dedicated to Lord Anson. The book should have settled the question. Instead it was received as one competing scurvy theory among many, in a medical culture still largely committed to the idea that scurvy resulted from bodily putrefaction rather than dietary deficiency — a framework in which citrus juice had no obvious mechanism and so carried no special authority over any other proposed remedy. The Navy's own Sick and Hurt Board considered and rejected formal adoption of citrus treatment as late as 1754, a year after the Treatise appeared. Lind's own text complicated matters further: alongside fresh citrus, he also recommended "rob," a juice concentrate boiled down for storage, not realizing the heating process destroyed the vitamin C that made the fresh fruit effective in the first place — an error that let skeptics point to inconsistent results from his own recommended remedy.

Haslar Hospital

In 1758 Lind was appointed chief physician of the Royal Naval Hospital at Haslar, near Gosport, then one of the largest hospitals in the world, where over his first two years he treated more than five thousand patients, over a thousand of them for scurvy — an ongoing, massive-scale confirmation of the disease's continuing toll on the fleet even as his own published cure sat largely unused. He continued publishing on naval hygiene, tropical disease, and shipboard fresh-water distillation, retiring in 1783 on a substantial pension; his son John succeeded him at Haslar.

The Long Delay

Full naval adoption of citrus juice as standard issue did not come until roughly 1795, a year after Lind's death, following further demonstrations by the naval physician Gilbert Blane and accumulating case evidence from other naval surgeons. Between the Salisbury trial and that final institutional acceptance lay forty-eight years — a gap now treated in the history of medicine as a case study in how strong evidence, generated by a rigorous experiment, can still languish for decades without the institutional will, clear communication, and practical logistics needed to convert a result into policy.

Why James Is Called a Genius

Lind's insight was procedural rather than theoretical: he did not understand vitamin C, would not live to see it identified, and was in fact wrong about the mechanism of his own cure — but he designed an experiment that isolated the variable that mattered by holding every other condition constant across matched patients, a method sound enough that its result survives intact even though his own explanation of it did not. That is the specific, underrated form of medical genius historians credit him with: not a theory of disease, but an experimental design so disciplined it produced the right answer despite the experimenter's own mistaken beliefs about why it worked. The James Lind Library and Alliance, named for him, treat this as the founding case of evidence-based medicine's comparative-trial method. The honest complication is his own — his simultaneous endorsement of heat-processed "rob" alongside fresh citrus, and the Treatise's diffuse, hedging presentation of a result that in retrospect looks unambiguous, are part of why his own contemporaries were not as certain as history has since made them appear.

Legacy

The Salisbury trial is now taught as the first controlled clinical trial in medical history, and the structure it established — matched groups, a single varied intervention, a controlled background condition — remains recognizable in every randomized clinical trial run today. Lind's name endures in the James Lind Library and the James Lind Alliance, institutions built explicitly to keep that founding lesson alive: that good evidence, however clearly gathered, still has to fight its way past institutional inertia before it saves lives.

Achievements

• Fellow of the Royal College of Physicians of Edinburgh
• Held posts at Royal Navy